@AparajitaSingh0 @LynchCancers @SoniaKupfer @DocStanich @priyanka_kanth Just wanted to remind you that we have scoped every 3 years in Finland even in MLH1 and MSH2 since the 1990s and have less CRCs than centers with shorter intervals… Be critical when r
RT @JamesKerwin9: Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrom…
RT @JamesKerwin9: Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrom…
RT @JamesKerwin9: Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrom…
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Pro... #amchelsinki https://t.co/qmKaJJuwPm
Longer interval between surveillance colonoscopies did not increase CRC rate in #Lynch syndrome #colorectalresearch #colorectalsurgery https://t.co/7FDYjAQul9
RT @Doctor_IMF: More colonoscopies in MLH1 does not reduce colorectal cancer rate. https://t.co/w5E9XpFVH1 Challenges dogma that polyps cau…
RT @Doctor_IMF: More colonoscopies in MLH1 does not reduce colorectal cancer rate. https://t.co/w5E9XpFVH1 Challenges dogma that polyps cau…
RT @Doctor_IMF: More colonoscopies in MLH1 does not reduce colorectal cancer rate. https://t.co/w5E9XpFVH1 Challenges dogma that polyps cau…
More colonoscopies in MLH1 does not reduce colorectal cancer rate. https://t.co/w5E9XpFVH1 Challenges dogma that polyps cause all CRC in LS!